AU2002234809B2 - Perylenequinones for use with immunotherapy agents - Google Patents

Perylenequinones for use with immunotherapy agents Download PDF

Info

Publication number
AU2002234809B2
AU2002234809B2 AU2002234809A AU2002234809A AU2002234809B2 AU 2002234809 B2 AU2002234809 B2 AU 2002234809B2 AU 2002234809 A AU2002234809 A AU 2002234809A AU 2002234809 A AU2002234809 A AU 2002234809A AU 2002234809 B2 AU2002234809 B2 AU 2002234809B2
Authority
AU
Australia
Prior art keywords
hypocrellin
tumor
cells
pdt
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002234809A
Other languages
English (en)
Other versions
AU2002234809A1 (en
Inventor
Beatrice Leveugle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncoquest Inc
Original Assignee
Oncoquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncoquest Inc filed Critical Oncoquest Inc
Publication of AU2002234809A1 publication Critical patent/AU2002234809A1/en
Application granted granted Critical
Publication of AU2002234809B2 publication Critical patent/AU2002234809B2/en
Assigned to ALTACHEM PHARMA, LTD reassignment ALTACHEM PHARMA, LTD Request for Assignment Assignors: ALTACHEM PHARMA, LTD, LEVEUGLE, BEATRICE
Assigned to ONCOQUEST INC. reassignment ONCOQUEST INC. Request for Assignment Assignors: ALTACHEM PHARMA, LTD
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002234809A 2001-01-30 2002-01-29 Perylenequinones for use with immunotherapy agents Ceased AU2002234809B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26467701P 2001-01-30 2001-01-30
US60/264,677 2001-01-30
PCT/IB2002/000267 WO2002060482A2 (en) 2001-01-30 2002-01-29 Perylenequinones for use with immunotherapy agents

Publications (2)

Publication Number Publication Date
AU2002234809A1 AU2002234809A1 (en) 2003-02-20
AU2002234809B2 true AU2002234809B2 (en) 2005-04-07

Family

ID=23007123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234809A Ceased AU2002234809B2 (en) 2001-01-30 2002-01-29 Perylenequinones for use with immunotherapy agents

Country Status (9)

Country Link
US (1) US20040110846A1 (enExample)
EP (1) EP1357944B1 (enExample)
JP (1) JP2004529091A (enExample)
CN (1) CN1665535A (enExample)
AT (1) ATE364398T1 (enExample)
AU (1) AU2002234809B2 (enExample)
CA (1) CA2436233C (enExample)
DE (1) DE60220642T2 (enExample)
WO (1) WO2002060482A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349965A (zh) * 2000-10-25 2002-05-22 中国科学院感光化学研究所 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
CA2548172A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
GB2442915B (en) * 2005-08-10 2009-12-16 Quest Pharmatech Inc Perylenequinone derivatives and uses thereof
US8454991B2 (en) * 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN102138640B (zh) * 2011-01-14 2012-12-05 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210B (zh) * 2017-09-06 2020-09-25 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
US20220175926A1 (en) * 2019-03-29 2022-06-09 The Brigham And Women's Hospital, Inc. Targeted synergistic cancer immunotherapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033470A2 (en) * 1997-01-10 1998-08-06 Altarex Corp. Substituted perylenequinones for use in photodynamic therapy
AU6921100A (en) * 1999-08-18 2001-03-13 Oncoquest Inc. Therapeutic binding agents against MUC-1 antigen and methods of their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
PT1009413E (pt) * 1997-09-05 2007-05-31 Univ California Utilização de oligonucleótidos imumoestimulantes para a prevenção ou tratamento da asma.
JP2002518342A (ja) * 1998-06-15 2002-06-25 アルタレックス コーポレイション 抗原を変化させることにより免疫応答を産生する治療組成物
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
PT1276501E (pt) * 2000-04-25 2006-05-31 Immunex Corp Metodo para o tratamento de tumores utilizando terapia fotodinamica
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
AU2002236988A1 (en) * 2001-02-06 2002-08-19 Novartis Ag Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033470A2 (en) * 1997-01-10 1998-08-06 Altarex Corp. Substituted perylenequinones for use in photodynamic therapy
AU6921100A (en) * 1999-08-18 2001-03-13 Oncoquest Inc. Therapeutic binding agents against MUC-1 antigen and methods of their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Drug Development Research Vol.42 No.3-4 (1997) pages 182-197 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Also Published As

Publication number Publication date
DE60220642T2 (de) 2008-02-21
US20040110846A1 (en) 2004-06-10
EP1357944A2 (en) 2003-11-05
DE60220642D1 (de) 2007-07-26
ATE364398T1 (de) 2007-07-15
EP1357944B1 (en) 2007-06-13
CA2436233A1 (en) 2002-08-08
CA2436233C (en) 2010-10-05
JP2004529091A (ja) 2004-09-24
CN1665535A (zh) 2005-09-07
WO2002060482A2 (en) 2002-08-08
WO2002060482A3 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
Ortel et al. Molecular mechanisms of photodynamic therapy
Pizova et al. Photodynamic therapy for enhancing antitumour immunity.
JP4148328B2 (ja) 細胞サイトゾルへの化合物の移入
Pass Photodynamic therapy in oncology: mechanisms and clinical use
Agostinis et al. Photodynamic therapy of cancer: an update
Zuluaga et al. Combination of photodynamic therapy with anti-cancer agents
Baldea et al. Photodynamic therapy in melanoma—an update
Via et al. Photochemotherapy in the treatment of cancer
US5177073A (en) Therapeutic compositions derived from photoactive compounds
US20090192071A1 (en) Use of photodynamic therapy to enhance treatment with immuno-modulating agents
Qiang et al. Combination of photodynamic therapy and immunomodulation: current status and future trends
AU2002234809B2 (en) Perylenequinones for use with immunotherapy agents
Marrelli et al. Applications of natural compounds in the photodynamic therapy of skin cancer
JP2023041779A (ja) 標的化併用療法
AU2002234809A1 (en) Perylenequinones for use with immunotherapy agents
EP1476190B1 (en) Amino-substituted hypocrellins for use as sonosensitizers
CN1531442A (zh) 用作光敏剂和声敏剂的苝醌
Korbelik et al. Exploitation of immune response‐eliciting properties of hypocrellin photosensitizer SL052‐based photodynamic therapy for eradication of malignant tumors
US7157477B2 (en) Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
AU2002215137A1 (en) Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
Singh et al. Photodynamic Therapy of Cancer: Quality and Prospective of Therapy based on Photosensitizer
HK1065709A (en) Perylenequinones for use as photosensitizers and sonosensitizers
Hussain Chapter-2 Combination Approaches in Photodynamic Therapies for Cancer
Korbelik Advances in the understanding of host response associated with tumor PDT
Zuluaga et al. PART A. COMBINATION THERAPY Chapter 1. Combination of Photodynamic Therapy with Anti-Cancer Agents

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ALTACHEM PHARMA, LTD

Free format text: FORMER APPLICANT(S): LEVEUGLE, BEATRICE; ALTACHEM PHARMA, LTD

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: ONCOQUEST INC.

Free format text: FORMER OWNER WAS: ALTACHEM PHARMA, LTD

MK14 Patent ceased section 143(a) (annual fees not paid) or expired